GE HealthCare has launched new editions of its three invasive cardiac software solutions, which secured FDA clearance in December 2024.
Brazilian Health Regulatory Agency (ANVISA) has granted approval for Telix Pharmaceuticals’ Illuccix, a prostate cancer imaging agent.
Subtle Medical has gained the CE mark in Europe for its software solution SubtleHD, designed to enhance the quality of MRI images.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback